Excluding pulmonary embolism in primary care using the Wells-rule in combination with a point-of care D-dimer test: a scenario analysis

BMC Fam Pract. 2010 Sep 13:11:64. doi: 10.1186/1471-2296-11-64.

Abstract

Background: In secondary care the Wells clinical decision rule (CDR) combined with a quantitative D-dimer test can exclude pulmonary embolism (PE) safely. The introduction of point-of-care (POC) D-dimer tests facilitates a similar diagnostic strategy in primary care.We estimated failure-rate and efficiency of a diagnostic strategy using the Wells-CDR combined with a POC-D-dimer test for excluding PE in primary care.We considered ruling out PE safe if the failure rate was <2% with a maximum upper confidence limit of 2.7%.

Methods: We performed a scenario-analysis on data of 2701 outpatients suspected of PE. We used test characteristics of two qualitative POC-D-dimer tests, as derived from a meta-analysis and combined these with the Wells-CDR-score.

Results: In scenario 1 (SimpliRed-D-dimer sensitivity 85%, specificity 74%) PE was excluded safely in 23.8% of patients but only by lowering the cut-off value of the Wells rule to <2. (failure rate: 1.4%, 95% CI 0.6-2.6%)In scenario 2 (Simplify-D-dimer sensitivity 87%, specificity 62%) PE was excluded safely in 12.4% of patients provided that the Wells-cut-off value was set at 0. (failure rate: 0.9%, 95% CI 0.2-2.6%)

Conclusion: Theoretically a diagnostic strategy using the Wells-CDR combined with a qualitative POC-D-dimer test can be used safely to exclude PE in primary care albeit with only moderate efficiency.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ambulatory Care
  • Antifibrinolytic Agents / blood
  • Decision Support Systems, Clinical / statistics & numerical data*
  • Diagnosis, Differential
  • Fibrin Fibrinogen Degradation Products* / analysis
  • Humans
  • Meta-Analysis as Topic
  • Point-of-Care Systems / statistics & numerical data*
  • Predictive Value of Tests
  • Primary Health Care / methods*
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis*
  • Qualitative Research
  • Reagent Kits, Diagnostic
  • Sensitivity and Specificity

Substances

  • Antifibrinolytic Agents
  • Fibrin Fibrinogen Degradation Products
  • Reagent Kits, Diagnostic
  • fibrin fragment D